FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023379416> ?p ?o ?g. }

• W2023379416 endingPage "2392" @default.
• W2023379416 startingPage "2389" @default.
• W2023379416 abstract "Dyslipidemia is a common problem among heart transplant (HT) recipients; it is a frequent risk factor in these patients that is exacerbated by immunosuppressive drugs. Statins are effective drugs to treat dyslipidemia in HT recipients, but control is suboptimal in some patients. Ezetimibe acts through inhibition of the enterohepatic recirculation, a mechanism different from but complementary to statins. Our objective was to assess the effect of the addition of ezetimibe to statin therapy among a population of HT patients.We included 19 stable patients on statin therapy with suboptimal control of cholesterol. Determinations were performed at baseline on statins and at 6 months (statins + ezetimibe). The analyzed variables were total cholesterol and fractions, triglycerides, cyclosporine levels, CPK, SGOT/SGPT, and bilirubin. The statistics were Student's t test for paired samples.The overall mean age was 59 +/- 9 years with 95% males and mean BMI 27.5 +/- 3.5. The time since HT was 7 +/- 3 years. The reason for HT included ischemic heart disease in 68%. Pre-HT risk factors included in arterial hypertension in 32% and insulin-dependent diabetes mellitus in 10%, Dyslipidemia occurred in 68%; hypertriglyceridemia in 16% and hyperuricemia in 21%. Immunosuppression was cyclosporine in 100% and steroids in 94%. Type of lipid-lowering agent was simvastatin in 5%; pravastatin, 32%; atorvastatin, 58%; fibrates, 10%. The ezetimibe dose was 10 mg/day in 95% of cases. When ezetimibe was added we observed differences in total cholesterol values (total cholesterol at baseline: 279 +/- 74, total cholesterol with ezetimibe: 198 +/- 47 mg/dL; P = .0001) and LDL-cholesterol values (LDL-cholesterol at baseline: 171 +/- 69, LDL-cholesterol with ezetimibe: 109 +/- 41 mg/dL; P = .001). The remaining variables did not show significant differences.The addition of ezetimibe to statin therapy among heart transplant patients was effective to control dyslipidemia and showed an excellent safety profile." @default.
• W2023379416 created "2016-06-24" @default.
• W2023379416 creator A5007441004 @default.
• W2023379416 creator A5018256836 @default.
• W2023379416 creator A5030209314 @default.
• W2023379416 creator A5050117091 @default.
• W2023379416 creator A5055713297 @default.
• W2023379416 creator A5055999164 @default.
• W2023379416 creator A5083957434 @default.
• W2023379416 creator A5085690750 @default.
• W2023379416 date "2007-09-01" @default.
• W2023379416 modified "2023-09-25" @default.
• W2023379416 title "Ezetimibe in Heart Transplantation: Initial Experience" @default.
• W2023379416 cites W1556011111 @default.
• W2023379416 cites W1979780302 @default.
• W2023379416 cites W2000684894 @default.
• W2023379416 cites W2019025981 @default.
• W2023379416 cites W2031313581 @default.
• W2023379416 cites W2031412970 @default.
• W2023379416 cites W2037199982 @default.
• W2023379416 cites W2047844719 @default.
• W2023379416 cites W2048995956 @default.
• W2023379416 cites W2052989238 @default.
• W2023379416 cites W2060847739 @default.
• W2023379416 cites W2062156645 @default.
• W2023379416 cites W2076059675 @default.
• W2023379416 cites W2084245368 @default.
• W2023379416 cites W2094665185 @default.
• W2023379416 cites W2122783053 @default.
• W2023379416 cites W2137914533 @default.
• W2023379416 cites W2148724358 @default.
• W2023379416 cites W2151332328 @default.
• W2023379416 cites W2154977429 @default.
• W2023379416 cites W2167530585 @default.
• W2023379416 cites W2169093103 @default.
• W2023379416 cites W4242915167 @default.
• W2023379416 cites W4246689148 @default.
• W2023379416 doi "https://doi.org/10.1016/j.transproceed.2007.06.043" @default.
• W2023379416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17889199" @default.
• W2023379416 hasPublicationYear "2007" @default.
• W2023379416 type Work @default.
• W2023379416 sameAs 2023379416 @default.
• W2023379416 citedByCount "11" @default.
• W2023379416 countsByYear W20233794162013 @default.
• W2023379416 countsByYear W20233794162014 @default.
• W2023379416 countsByYear W20233794162015 @default.
• W2023379416 countsByYear W20233794162019 @default.
• W2023379416 crossrefType "journal-article" @default.
• W2023379416 hasAuthorship W2023379416A5007441004 @default.
• W2023379416 hasAuthorship W2023379416A5018256836 @default.
• W2023379416 hasAuthorship W2023379416A5030209314 @default.
• W2023379416 hasAuthorship W2023379416A5050117091 @default.
• W2023379416 hasAuthorship W2023379416A5055713297 @default.
• W2023379416 hasAuthorship W2023379416A5055999164 @default.
• W2023379416 hasAuthorship W2023379416A5083957434 @default.
• W2023379416 hasAuthorship W2023379416A5085690750 @default.
• W2023379416 hasConcept C126322002 @default.
• W2023379416 hasConcept C134018914 @default.
• W2023379416 hasConcept C2776329913 @default.
• W2023379416 hasConcept C2776839432 @default.
• W2023379416 hasConcept C2776919658 @default.
• W2023379416 hasConcept C2777482532 @default.
• W2023379416 hasConcept C2778096610 @default.
• W2023379416 hasConcept C2778163477 @default.
• W2023379416 hasConcept C2778657065 @default.
• W2023379416 hasConcept C2778913445 @default.
• W2023379416 hasConcept C2779519902 @default.
• W2023379416 hasConcept C2908647359 @default.
• W2023379416 hasConcept C2911091166 @default.
• W2023379416 hasConcept C555293320 @default.
• W2023379416 hasConcept C71924100 @default.
• W2023379416 hasConcept C90924648 @default.
• W2023379416 hasConcept C98274493 @default.
• W2023379416 hasConcept C99454951 @default.
• W2023379416 hasConceptScore W2023379416C126322002 @default.
• W2023379416 hasConceptScore W2023379416C134018914 @default.
• W2023379416 hasConceptScore W2023379416C2776329913 @default.
• W2023379416 hasConceptScore W2023379416C2776839432 @default.
• W2023379416 hasConceptScore W2023379416C2776919658 @default.
• W2023379416 hasConceptScore W2023379416C2777482532 @default.
• W2023379416 hasConceptScore W2023379416C2778096610 @default.
• W2023379416 hasConceptScore W2023379416C2778163477 @default.
• W2023379416 hasConceptScore W2023379416C2778657065 @default.
• W2023379416 hasConceptScore W2023379416C2778913445 @default.
• W2023379416 hasConceptScore W2023379416C2779519902 @default.
• W2023379416 hasConceptScore W2023379416C2908647359 @default.
• W2023379416 hasConceptScore W2023379416C2911091166 @default.
• W2023379416 hasConceptScore W2023379416C555293320 @default.
• W2023379416 hasConceptScore W2023379416C71924100 @default.
• W2023379416 hasConceptScore W2023379416C90924648 @default.
• W2023379416 hasConceptScore W2023379416C98274493 @default.
• W2023379416 hasConceptScore W2023379416C99454951 @default.
• W2023379416 hasIssue "7" @default.
• W2023379416 hasLocation W20233794161 @default.
• W2023379416 hasLocation W20233794162 @default.
• W2023379416 hasOpenAccess W2023379416 @default.
• W2023379416 hasPrimaryLocation W20233794161 @default.
• W2023379416 hasRelatedWork W1952267466 @default.

• next